Cumberland pharmaceuticals inc stock
WebJul 22, 2009 · THIS WARRANT TO PURCHASE COMMON STOCK OF CUMBERLAND PHARMACEUTICALS, INC. (the “Warrant”) is issued as of July 22, 2009, by … WebDec 21, 2024 · The estimated net worth of Martin E. Cearnal is at least $382,925.28 as of July 30th, 2024. Mr. Cearnal owns 165,054 shares of Cumberland Pharmaceuticals stock worth more than $382,925 as of February 24th. This net worth estimate does not reflect any other assets that Mr. Cearnal may own.
Cumberland pharmaceuticals inc stock
Did you know?
WebJul 17, 2024 · Cumberland Pharmaceuticals' mailing address is 2525 WEST END AVENUE SUITE 950, NASHVILLE TN, 37203. The official website for the company is … Web1. Grant of Option. Cumberland Pharmaceuticals Inc. (the “Company”), a Tennessee corporation, hereby grants to the Participant an option (the “Option”) to purchase from …
WebCumberland Pharmaceuticals Inc. (the “Company”), a Tennessee corporation, hereby grants to the Participant an option (the “Option”) to purchase from the Company up to the number of shares of common stock (the “Shares”) described in the attached Notice of Stock Option Grant (the “Notice”). WebApr 6, 2024 · Cumberland Pharmaceuticals Inc lowest stock price was $1.89 and its highest was $2.91 in the past 12 months. What is Cumberland Pharmaceuticals Inc’s market cap? ... Cumberland Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. ...
WebCumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2024 financial results and provided a Company … Discover historical prices for CPIX stock on Yahoo Finance. View daily, weekly or … Find the latest Cumberland Pharmaceuticals Inc. (CPIX) stock … Stocks sink after Fed minutes despite cooler inflation: Stock market news … Find out all the key statistics for Cumberland Pharmaceuticals Inc. … Cumberland Pharmaceuticals Inc. (CPIX) NasdaqGS - NasdaqGS Real Time … Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty … Cumberland Pharmaceuticals Inc. (CPIX) NasdaqGS - NasdaqGS Real Time … Cumberland Pharmaceuticals Inc. 1600 West End Avenue Nashville, TN 37203 … See Cumberland Pharmaceuticals Inc. (CPIX) stock analyst estimates, … Get the detailed quarterly/annual income statement for Cumberland … WebApr 14, 2024 · Acadian Asset Management LLC raised its holdings in shares of Cumberland Pharmaceuticals by 27.8% in the 1st quarter. Acadian Asset Management LLC now owns 188,243 shares of the specialty...
WebApr 6, 2024 · The Cumberland Pharmaceuticals Inc. stock price gained 2.55% on the last trading day (Thursday, 6th Apr 2024), rising from $1.96 to $2.01. During the last trading …
WebApr 11, 2024 · 54,9%. More Financials. Company. Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, … chrome redirectsWebMar 24, 2024 · Cumberland Pharmaceuticals, Inc. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Cumberland Pharmaceuticals, Inc.’s trailing 12-month revenue is $41.2 million with a -16.9% profit margin. Year-over-year quarterly sales growth most recently was 40.7%. There are not analysts providing … chrome redirector extensionWebFeb 10, 2024 · Cumberland Pharmaceuticals Inc. Common Stock (CPIX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Skip to … chrome redirect share clickhttp://www.cumberlandpharma.com/ chrome redirect malware removalWebMar 28, 2024 · Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products … chrome redirectorWebFind the latest Cumberland Pharmaceuticals Inc. (CPIX) stock quote, history, news and other vital information to help you with your stock trading and investing. chrome redirect scannerWebOur gross margins remained attractive, resulting in $8.5 million in cash generated from operations. Our balance sheet remained strong as we ended the year with $93 million in total assets – including $20 million in cash, $57 million in liabilities and $36 million of shareholders’ equity. chrome redirects searches